In the case of drugs, the packaging not only contributes to the marketing mix but also has a significant impact on the qualities, use, and shelf life of the product. The safety of children, the elderly, and medications from damage, germs, the outside environment, and microbes must all be considered in drug packaging. Types of pharmaceutical packaging:
- Packaging
- Aluminium foil
- Vials/Bottles for Injectables
- Boxes
- Board
- Paper Lamini tubes
- Combinations Based on PVC
The packaging used by the pharmaceutical industry varies from drug to medicament and frequently includes three tiers, referred to as primary, secondary, and tertiary packaging.
1. The items that initially surround and support the product, also known as the primary packaging system, include blister packs, prefilled syringes, IV containers, ampoules and vials, prefilled syringes, and other items. Blister packs, prefilled syringes, IV containers, ampoules and vials, prefilled syringes, and other items that actually come into contact with the product or that may have an immediate impact on its shelf life are examples of aluminium foil subcomponents. 1. The primary packaging system consists of the materials that first enclose and support the product, or those package elements.
2. Injection trays, cartons, and boxes are utilised as secondary packaging solutions to group large products together outside of the main container.
3. For bulk handling and shipping, tertiary packaging solutions such barrels, containers, edge guards, etc. are used.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation